Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC reduced its holdings in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 26.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 10,423 shares of the company’s stock after selling 3,743 shares during the quarter. Janus Henderson Group PLC’s holdings in Henry Schein were worth $760,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of HSIC. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Henry Schein by 15.0% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 40,512 shares of the company’s stock valued at $2,597,000 after purchasing an additional 5,299 shares during the last quarter. Blue Trust Inc. grew its stake in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares during the last quarter. TCW Group Inc. increased its position in Henry Schein by 72.6% in the second quarter. TCW Group Inc. now owns 24,740 shares of the company’s stock worth $1,586,000 after buying an additional 10,407 shares during the period. Raymond James & Associates lifted its stake in Henry Schein by 2.0% in the second quarter. Raymond James & Associates now owns 292,166 shares of the company’s stock valued at $18,728,000 after buying an additional 5,763 shares during the last quarter. Finally, First Citizens Bank & Trust Co. boosted its holdings in shares of Henry Schein by 12.6% during the second quarter. First Citizens Bank & Trust Co. now owns 49,993 shares of the company’s stock valued at $3,205,000 after acquiring an additional 5,585 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Down 0.6 %

Shares of Henry Schein stock opened at $76.60 on Friday. The business has a fifty day simple moving average of $72.25 and a 200-day simple moving average of $70.06. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The firm has a market cap of $9.55 billion, a price-to-earnings ratio of 31.52, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSICGet Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the company earned $1.32 EPS. Henry Schein’s revenue was up .4% on a year-over-year basis. On average, equities analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. Evercore ISI lifted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Seven research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Read Our Latest Stock Report on HSIC

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.